MSK Publications Trivia: In Which Journals did MSK Authors Most Frequently Publish in 2019?

Posted on by

MSK Authors published over 5,000 works in 2019, including journal articles, meeting abstracts, conference papers, and books. Here are the 10 most common journals for the 3,240 articles collected in Synapse* for 2019, along with their journal impact factor, taken from the Journal Citation Report produced by Clarivate Analytics. 

2019 Top Journals

This chart comes from the 2019 Synapse Publications Report, our annual review of MSK’s research publications. Check it out to see more trivia about our authors and their publications. 

For more information, feel free to contact us. 

*Note: In Synapse this category also includes editorials, letters, guidelines, and reviews.

Advancing Authorship Webinar: Preprints in the Time of COVID-19

Posted on by

Join us for the next event in our Advancing Authorship MSK Library Series: Preprints in the Time of COVID-19. 

During the COVID-19 pandemic, research has accelerated at an unprecedented pace and it has become more critical than ever for scientists to rapidly share their research results. Increasingly, researchers are relying on preprints to quickly communicate and share findings. In this session, we will explore the benefits and challenges of preprints. You’ll hear from MSK researchers who have published preprints on COVID-19, plus the Co-founder of two popular preprint servers, bioRxiv and medRxiv. 

Date: Friday, September 25
Time: 12:30 PM – 2:00 PM
Location: Zoom Webinar – REGISTER NOW

Speakers:

John Inglis, PhD – Dr Inglis is the Co-founder of bioRxiv and medRxiv, Cold Spring Harbor Laboratory’s preprint services for the life and health sciences.  He is also the founding Executive Director and Publisher of Cold Spring Harbor Laboratory Press in New York, a not-for-profit publisher of journals, books, and online media in molecular and cellular biology. He graduated from the University of Edinburgh Medical School with a PhD in immunology and was previously Assistant Editor of The Lancet, founding editor of Trends in Immunology, and managing editor of other Trends journals.  Follow John on Twitter @JohnRInglis.

Elizabeth Robilotti, MD, MPH, Dept. of Medicine, Associate Chief Medical Epidemiologist/Assistant Attending Infectious Diseases. Dr. Robilotti’s clinical practice directly influences her research in infection prevention and hospital epidemiology. She is focused on advancing the prevention of healthcare-associated infections  in high risk cancer patients through the application of molecular epidemiology. Through collaborations with the Microbiology Laboratory, Dr. Robilotti also works to refine new techniques  for more accurate and thorough surveillance and outbreak investigation. 

Lior Braunstein, MD, Dept. of Radiation Oncology, MSK – Board-certified radiation oncologist and scientist who specializes in treating breast cancer, prostate cancer, and primary and metastatic brain tumors. Dr. Braunstein has expertise in using advanced radiation therapy techniques, such as intensity-modulated radiation therapy, image-guided radiation therapy, stereotactic body radiation therapy, and stereotactic radiosurgery. His research is focused on molecular and biomarker-driven clinical trials, cancer epidemiology and outcomes analyses, and translational studies. As part of his clinical and scientific work, Dr. Braunstein serves on several national and international committees including the American Society of Clinical Oncology, the American Society for Radiation Oncology, and NRG Oncology, among others.

Malin Hultcrantz, MD, PhD, Dept. of Medicine, MSK – Hematologist with Clinical Expertise in Multiple Myeloma; Smoldering Myeloma; Monoclonal Gammopathy of Undetermined Significance (MGUS); Related Plasma Cell Disorders